The roles of cyclic adenosine monophosphate- and cyclic guanosine monophosphate-dependent protein kinase pathways in hydrogen peroxide-induced contractility of microvascular lung pericytes

Journal of Trauma

Volumn 55, Issue 4, 2003, Pages 677-684

  Williams, Mallory ^a   Kerkar, Sid ^a   Tyburski, James G ^a   Steffes, Christopher P ^a   Carlin, Arthur M ^a   Wilson, Robert F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ARDS; Microvascular permeability; Pericyte; Sepsis

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; GUANYLATE CYCLASE INHIBITOR; HYDROGEN PEROXIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ARTICLE; BIPHASIC RESPONSE; CAPILLARY PERMEABILITY; CELL ACTIVITY; CELL CONTRACTILITY; CELL MOTION; CELL VIABILITY; CONTROLLED STUDY; INFLAMMATION; LUNG CAPILLARY; MICROVASCULATURE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RAT; SEPSIS; SIGNAL TRANSDUCTION; VASODILATATION;

ADENINE; ADENYLATE CYCLASE; ANALYSIS OF VARIANCE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; HYDROGEN PEROXIDE; ISOQUINOLINES; LUNG; MALE; MUSCLE CONTRACTION; OXADIAZOLES; PERICYTES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SULFONAMIDES;

EID: 0142178251     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000086180.11523.8D     Document Type: Article

References (25)

1. Speyer CL, Steffes CP, Tyburski JG, Ram JL. Lipopolysaccharide induces relaxation in lung pericytes by an iNOS-independent mechanism. Am J Physiol. 2000; 278; L880-L887.
2. Buchanan RA, Wagner RC. Morphometric changes in pericyte-capillary endothelial cell association correlated with vasoactive stimulus. Microcirc Endothelium Lymphatics. 1990; 6; 159-180.
3. Gilbert RP. Mechanisms of the hemodynamic effects of endotoxin. Physiol Rev. 1960; 40; 245-279.
4. Speyer C, Steffes CP, Ram JL. Effects of vasoactive mediators on the rat lung pericyte; quantitative analysis of contraction on collagen lattice matrices. Microvasc Res. 1999; 57; 134-143.
5. Kerkar S, Speyer C, Tyburski JG, Steffes CP. Reactive oxygen metabolites induce a biphasic contractile response in microvascular lung pericytes. J Trauma. 2001; 51; 440-445.
6. Diaz-Flores LR, Guttierez H, Varela N, Rancel N, Valladares F. Microvascular pericytes; a review of their morphological and functional characteristics. Histol Histopathol. 1991; 6; 269-286.
7. Tilton RG, Kilo C, Williamson JR, Murch DW. Differences in pericyte contractile function in rat cardiac and skeletal muscle microvasculatures. Microvasc Res. 1979; 18; 336-352.
8. Cohen MP, Frank RM, Khalifa AA. Collagen production by cultured retinal capillary pericytes. Invest Ophthalmol Vis Sci. 1980; 19; 90-94.
9. Simms D. Recent advances in pericyte biology; implications for health and disease. Can J Cardiol. 1991; 10; 431-443.
10. Joyce NC, Haire MF, Palade GE. Contractile proteins in pericytes; immunocytochemical evidence for presence of two isomyosins in graded concentrations. J Cell Biol. 1985; 100; 1387-1395.
11. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med. 1997; 22; 269-285.
12. Rahman I, Gilmour PS, Jimenez LA, Macnee W. Oxidative stress and TNF-alpha induce histone acetylation and NFkappa B/AP-1 activation in alveolar epithelial cells. Mol Cell Biochem. 2002; 234-235; 239-248.
13. 2+ sensitivity in airway smooth muscle by inhibiting rMLC phosphorylation. Am J Physiol. 1999; 277 (4 pt 1); L816-L822.
14. Dhanakoti SN, Gao Y, Nguyen MQ, Raj JU. Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol. 2000; 88; 1637-1642.
15. Eckly-Michel A, Martin V, Lugnier C. Involvement of cyclin nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br J Pharmacol. 1997; 122; 158-164.
16. Pelligrino DA, Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol. 1998; 56; 1-18.
17. Francis SH, Corbin JD. Cyclic nucleotide-dependent protein kinases; intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci. 1999; 36; 275-328.
18. Jiang H, Colbran JL, Francis SH, Corbin JD. Direct evidence to cross-activation of cGMP-dependent kinase by cAMP in pig coronary arteries. J Biol Chem. 1992; 267; 1015-1019.
19. 2+ by cAMP in vascular smooth muscle cells. Am J Physiol. 1990; 258; C399-C407.
20. Pfitzer G. Signal transduction in smooth muscle invited review; regulation of myosin phosphorylation in smooth muscle. J Appl Physiol. 2001; 91; 497-503.
21. Noiman ES. Phosphorylation of smooth muscle myosin light chains by cAMP-dependent protein kinase. J Biol Chem. 1980; 255; 11067-11070.
22. Murthy KS, Zhou H, Makhlouf GM. PKA-dependent activation of PDE3A and PDE4, and inhibition of adenylyl cyclase V/VI in smooth muscle. Am J Physiol. 2002; 282; C508-C517.
23. Silver PJ. Regulation of contractile activity in vascular smooth muscle by protein kinases. Rev Clin Basic Pharm. 1985; 5; 341-395.
24. Toyoshima H, Nasa Y, Hashizume Y, et al. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle. J Cardiovasc Pharmacol. 1998; 32; 543-551.
25. Sonnenburg WK, Beavo JA. Cyclic GMP and regulation of cyclic nucleotide hydrolysis. Adv Pharmacol. 1994; 26; 87-114.